- Title
- BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY
- Creators
- Krishnansu S. Tewari - University of California, IrvineMichael W. Sill - NRG OncologyRobert L. Coleman - The University of Texas MD Anderson Cancer CenterCarol Aghajanian - Memorial Sloan Kettering Cancer CenterRobert Mannel - University of Oklahoma Health Sciences CenterPaul A. DiSilvestro - Women & Infants Hospital of Rhode IslandMatthew Powell - Barnes-Jewish HospitalLeslie M. Randall - University of California, IrvineJohn Farley - Creighton UniversityStephen C. Rubin - Fox Chase Cancer CenterBradley J. Monk - University of Arizona
- Publication Details
- Gynecologic oncology, Vol.159(1), pp.79-87
- Identifiers
- 991005969061302656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER: OVERALL SURVIVAL AND EXPLORATORY ANALYSES OF A RANDOMIZED PHASE II NRG ONCOLOGY/GYNECOLOGIC ONCOLOGY GROUP STUDY
Gynecologic oncology, Vol.159(1), pp.79-87
07/26/2020
PMID: 32723679
Related links
Metrics
5 Record Views